Early Treatment-Resistance in First Episode Psychosis
The findings indicate that longer inpatient stay, an increased number of antipsychotics, and possibly a more extended prodrome may serve as markers for non-clozapine TR in FEP. Further research is necessary to establish the robustness of these variables as early-stage TR markers.
Authors
- Johanna Strauß
- Mattia Campana (ORCID: https://orcid.org/0000-0003-4596-4287)
- Irina Papazova (ORCID: https://orcid.org/0000-0001-8265-788X)
- Elias M. Wagner (ORCID: https://orcid.org/0000-0002-7147-6167)
- Lisa Löhrs (ORCID: https://orcid.org/0000-0001-6578-3649)
- Piyumi Fernando
- Alkomiet Hasan (ORCID: https://orcid.org/0000-0002-2662-9742)
- Peter Falkai
Institutions
- University Hospital Augsburg (DE)
- German Center for Diabetes Research (DE)
- Bezirkskrankenhaus Augsburg (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Pharmacopsychiatry
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1055/a-2421-2411
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00